IL98674A0 - Novel pyrimidine derivatives which are angiotensin ii receptor antagonists,their methods of preparation and pharmaceutical compositions in which they are present - Google Patents
Novel pyrimidine derivatives which are angiotensin ii receptor antagonists,their methods of preparation and pharmaceutical compositions in which they are presentInfo
- Publication number
- IL98674A0 IL98674A0 IL98674A IL9867491A IL98674A0 IL 98674 A0 IL98674 A0 IL 98674A0 IL 98674 A IL98674 A IL 98674A IL 9867491 A IL9867491 A IL 9867491A IL 98674 A0 IL98674 A0 IL 98674A0
- Authority
- IL
- Israel
- Prior art keywords
- angiotensin
- preparation
- methods
- pharmaceutical compositions
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
- C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/58—Two sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9008346A FR2663930B1 (en) | 1990-07-02 | 1990-07-02 | NOVEL PYRIMIDINE DERIVATIVES ANTAGONISTS OF ANGIOTENSIN II RECEPTORS; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR9014963A FR2669928B1 (en) | 1990-11-29 | 1990-11-29 | NOVEL PYRIMIDINE DERIVATIVES ANTIAGONISTS OF ANGIOTENSIN II RECEPTORS; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
Publications (1)
Publication Number | Publication Date |
---|---|
IL98674A0 true IL98674A0 (en) | 1992-07-15 |
Family
ID=26228124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL98674A IL98674A0 (en) | 1990-07-02 | 1991-06-30 | Novel pyrimidine derivatives which are angiotensin ii receptor antagonists,their methods of preparation and pharmaceutical compositions in which they are present |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0465323A1 (en) |
JP (1) | JPH04230370A (en) |
KR (1) | KR920002555A (en) |
AU (1) | AU7949191A (en) |
CA (1) | CA2045327A1 (en) |
IE (1) | IE912114A1 (en) |
IL (1) | IL98674A0 (en) |
NZ (1) | NZ238785A (en) |
PT (1) | PT98171A (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250548A (en) * | 1990-09-10 | 1993-10-05 | Abbott Laboratories | Angiotensin II receptor antagonists |
FR2672892B1 (en) * | 1991-02-20 | 1994-01-14 | Synthelabo | DERIVATIVES OF 4-PYRIMIDINONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
US5252574A (en) * | 1991-04-26 | 1993-10-12 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted thiophene or furan |
IT1250749B (en) * | 1991-08-02 | 1995-04-21 | Luso Farmaco Inst | HETEROCYCLIC COMPOUNDS ACTIVATED IN II ANTAGONIST |
AU658426B2 (en) * | 1991-08-15 | 1995-04-13 | Zeneca Limited | Substituted heterocycles |
AU653665B2 (en) * | 1992-01-17 | 1994-10-06 | Solahart Industries Pty Ltd | Solar hot water systems |
IL104756A0 (en) * | 1992-02-17 | 1993-06-10 | Ciba Geigy Ag | Composition for the treatment of glaucoma |
FR2688505B1 (en) * | 1992-03-16 | 1994-05-06 | Synthelabo | NEW PROCESS FOR THE PREPARATION OF 4-PYRIMIDINONES. |
US5338740A (en) * | 1993-07-13 | 1994-08-16 | Pfizer Inc. | Angiotensin II receptor antagonists |
IT1283620B1 (en) * | 1996-04-19 | 1998-04-22 | Luso Farmaco Inst | "PIRIMIDIN-4-ONI N-3 SUBSTITUTED FOR ACTIVITIES WITH THE ANTAGONIST" |
US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
US6583148B1 (en) | 1999-04-08 | 2003-06-24 | Krenitsky Pharmaceuticals, Inc. | Neurotrophic substituted pyrimidines |
SE9903028D0 (en) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
JP5154728B2 (en) | 2000-07-24 | 2013-02-27 | クレニツキー・ファーマシューティカルズ,インコーポレイテッド | Substituted 5-alkynylpyrimidines with neurotrophic activity |
JP2005232081A (en) * | 2004-02-19 | 2005-09-02 | Bayer Cropscience Ag | Utilization of benzylpyrimidine derivative as agricultural and horticultural bactericide |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
WO2010119700A1 (en) | 2009-04-17 | 2010-10-21 | 興和株式会社 | Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same |
WO2011040004A1 (en) * | 2009-09-29 | 2011-04-07 | 興和株式会社 | Novel phenylpyridine derivative and medicinal agent comprising same |
WO2011105099A1 (en) * | 2010-02-25 | 2011-09-01 | 興和株式会社 | Compound containing a novel 4-alkoxypyridine formation and medicine containing same |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
KR102057877B1 (en) | 2012-07-18 | 2019-12-20 | 노스 앤드 사우스 브라더 파마시 인베스트먼트 컴파니 리미티드 | Nitrogenous heterocyclic derivatives and their application in drugs |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
CN114292238B (en) * | 2022-01-07 | 2024-04-12 | 河北工业大学 | C6-alkylthio/amino substituted pyrimidine derivative and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2659694A1 (en) * | 1976-12-31 | 1978-07-13 | Bayer Ag | PROCESS FOR THE PREPARATION OF SUBSTITUTED CHLOROPYRIMIDINES |
-
1991
- 1991-06-19 IE IE211491A patent/IE912114A1/en unknown
- 1991-06-24 CA CA002045327A patent/CA2045327A1/en not_active Abandoned
- 1991-06-28 NZ NZ238785A patent/NZ238785A/en unknown
- 1991-06-28 EP EP91401773A patent/EP0465323A1/en not_active Withdrawn
- 1991-06-30 IL IL98674A patent/IL98674A0/en unknown
- 1991-07-01 AU AU79491/91A patent/AU7949191A/en not_active Abandoned
- 1991-07-01 PT PT98171A patent/PT98171A/en not_active Application Discontinuation
- 1991-07-02 KR KR1019910011214A patent/KR920002555A/en not_active Application Discontinuation
- 1991-07-02 JP JP3186965A patent/JPH04230370A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ238785A (en) | 1993-10-26 |
IE912114A1 (en) | 1992-01-15 |
KR920002555A (en) | 1992-02-28 |
CA2045327A1 (en) | 1992-01-03 |
PT98171A (en) | 1993-08-31 |
EP0465323A1 (en) | 1992-01-08 |
JPH04230370A (en) | 1992-08-19 |
AU7949191A (en) | 1992-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL98674A0 (en) | Novel pyrimidine derivatives which are angiotensin ii receptor antagonists,their methods of preparation and pharmaceutical compositions in which they are present | |
IL97576A0 (en) | Novel pyrazole derivatives which are angiotensin ii receptor antagonists,their methods of preparation and pharmaceutical compositions in which they are present | |
IL99246A0 (en) | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them | |
NZ235726A (en) | Substituted pyrimidine derivatives; their preparation and pharmaceutical compositions | |
NZ301265A (en) | Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof | |
IL118519A0 (en) | Pyrimidinedione pyrimidinetrione triazinedione tetrahydroquinazolinedione derivatives their preparation and pharmaceutical compositions containing them | |
HUP9901245A3 (en) | Indole derivatives useful as endothelin receptor antagonists, preparation and use thereof, pharmaceutical compositions containing these compounds | |
IL92558A0 (en) | Pharmaceutical compositions comprising pyrimidine derivatives,certain novel such derivatives and their preparation | |
HUP9603298A3 (en) | Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, and their use for the preparation of pharmaceutical compositions | |
IL127056A (en) | Aryl pyrimidine derivatives, their preparation and pharmaceutical compositions comprising them | |
HUP0004150A3 (en) | Indazole derivatives as tyrosine kinase receptor antagonists and pharmaceutical compositions containing them | |
NZ237041A (en) | Substituted 1h-indole derivatives, preparation, pharmaceutical compositions and intermediates thereof | |
IL96577A0 (en) | Heterocyclic substituted acylaminothiazoles,their preparation and pharmaceutical compositions containing them | |
IL96385A0 (en) | Indole derivatives,their preparation and pharmaceutical compositions containing them | |
IL100917A0 (en) | Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them | |
ZA945656B (en) | 1-Benzenesfulfonyl-1,3-dihydro-indol-2-one derivatives their preparation and pharmaceutical compositions in which they are present | |
IL120141A (en) | Substituted quinazoline derivatives process for their preparation and pharmaceutical compositions containing them | |
HUP9901296A3 (en) | Substituted piperidine derivatives as nmda receptor antagonists and pharmaceutical compositions containing them | |
IL103571A0 (en) | Water soluble camptothecin derivatives,their preparation and pharmaceutical compositions containing them | |
HUP0002902A3 (en) | 3-substituted 3,4 dyhydro-thieno[2,3-d]pyrimidine derivatives and their use for the preparation of pharmaceutical compositions | |
SI0918059T1 (en) | Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them | |
NZ236625A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
IL118410A0 (en) | Substituted camptothecin derivatives their preparation and pharmaceutical compositions containing them | |
AU661017B2 (en) | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present | |
IL96769A0 (en) | Substituted 3,4-annelated benzimidazol-2(1h)-ones,their preparation and pharmaceutical compositions containing them |